ArticlePLOS global public health2025

Barriers to viral suppression in children aged 9 years or younger on dolutegravir-based antiretroviral therapy in Malawi, a mixed-methods study.

Khumbo Phiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.